FDA aiming to modernize 510(k) process that many radiology devices must go through

The U.S. Food and Drug Administration announced Sept. 6 that it is hoping to modernize the premarket notification 510(k) program that many radiology devices must go through.

As part of the process, the agency released three draft guidance documents, aimed at supporting efforts to strengthen the process. They cover topics including best practices for premarket submission, recommendations on the use of clinical data, and evidentiary expectations for implant devices.

“We recognize there is a need to continue to modernize the 510(k) Program to improve the safety of medical devices while continuing to bring critical devices to patients,” the FDA said in an announcement. “Issuing these draft guidances marks an important step in the FDA’s Center for Devices and Radiological Health’s ongoing commitment to optimize the clarity, predictability, and consistency of the 510(k) Program…”

As part of the changes, beginning Oct. 1, all 510(k) submissions must be submitted electronically using the eSTAR platform. The agency also is accepting comments on the draft guidance documents by Dec. 6 and plans to host a webinar on Oct. 26 to discuss the process.

Marty Stempniak

Marty Stempniak has covered healthcare since 2012, with his byline appearing in the American Hospital Association's member magazine, Modern Healthcare and McKnight's. Prior to that, he wrote about village government and local business for his hometown newspaper in Oak Park, Illinois. He won a Peter Lisagor and Gold EXCEL awards in 2017 for his coverage of the opioid epidemic. 

Around the web

News of an incident is a stark reminder that healthcare workers and patients aren’t the only ones who need to be aware around MRI suites.

The ACR hopes these changes, including the addition of diagnostic performance feedback, will help reduce the number of patients with incidental nodules lost to follow-up each year.

And it can do so with almost 100% accuracy as a first reader, according to a new large-scale analysis.